ResearchJun 22, 20260 views

Fusion peptide-functionalized amniotic membrane scaffold promotes diabetic burn repair by modulating neurovascular coupling.

Peptide-functionalized scaffolds just set a new bar for diabetic burn wound research. Xiao and colleagues engineered a fusion peptide–amniotic membrane combo that doesn’t just patch wounds—it actively jumpstarts nerve and blood vessel regrowth. That’s a big deal for diabetic wounds, which are notorious for slow healing and high amputation rates.

P

Int J Biol Macromol

by Xiao Z, Chen S, Luo H et al.

Fusion peptide-functionalized amniotic membrane scaffold promotes diabetic burn repair by modulating neurovascular coupling. Xiao Z(1), Chen S(2), Luo H(3), Tong X(4), Zhou L(1), Liu W(5), Yang Y(6), Yang J(1), Tian H(7), Zhang Y(8). Author information: (1)Department of Medical Cosmetology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410028, China. (2)Department of Plastic and Laser Cosmetology, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People's Hospital, Changsha, 410005, China. (3)Department of Plastic Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China. (4)Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. (5)Department of Orthopaedics, Third Xiangya Hospital, Central South University, Changsha, 410013, China. (6)Department of Research Development, Jiangxi Ruiji Biotechnology Engineering Co., Ltd., Nanchang, 330098, China; School of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China. (7)International Medical Department, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410013, China. Electronic address: 30440281@qq.com. (8)Department of Orthopedics, First Hospital of Shanxi Medical University, Taiyuan, 030001, China; Department of Orthopedic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. Electronic address: zhangyu171@126.com. Diabetic wounds are a severe complication of diabetes, characterized by impaired neurovascular regeneration and chronic inflammation, which leads to high rates of amputation and a diminished quality of life. To overcome this challenge, we engineered a biofunctional composite scaffold by immobilizing a rationally designed fusion peptide (FP) onto a decellularized amniotic membrane (dAM) matrix. The FP integrates the neuroactive IKVAV sequence and the angiogenic QK motif through a specific collagen-binding domain (CBD), enabling stable and uniform anchoring within the dAM's collagen network. Comprehensive in vitro evaluations demonstrated that the dAM-FP scaffold significantly outperformed control scaffolds (dAM alone or modified with single peptides) in promoting the migration of endothelial progenitor cells and rat schwann cells, fostering capillary-like tube formation, and stimulating robust neurite outgrowth from PC12 cells. In a diabetic mouse full-thickness burn wound model, treatment with the dAM-FP scaffold resulted in markedly accelerated wound closure kinetics. Most importantly, histological and immunofluorescence analyses confirmed its superior dual functionality: the scaffold simultaneously and synergistically enhanced the regeneration of both microvascular networks and sensory nerve fibers within the healing wound bed. This study suggests that CBD-mediated co-presentation of neurogenic and angiogenic cues on a natural ECM scaffold may contribute to neurovascular regeneration in diabetic burn wound repair. The dAM-FP scaffold thus represents a promising biomaterial strategy for refractory diabetic wounds, while further validation is still required before clinical translation. Copyright © 2026. Published by Elsevier B.V. Conflict of interest statement: Declaration of competing interest The authors state that there are no financial or personal competing interests to declare.

Here’s what they did: They took a decellularized amniotic membrane (dAM) and anchored a custom fusion peptide (FP) to its collagen matrix. This FP wasn’t just any sequence. It combined IKVAV (neuroactive), QK (angiogenic), and a collagen-binding domain for stable attachment. The result? A scaffold that delivers both nerve and vessel growth cues right where they’re needed.

Lab tests showed this dAM-FP scaffold left controls in the dust:

Endothelial progenitor cells and Schwann cells migrated faster

Capillary-like tubes formed more easily

PC12 cells threw out longer neurites

But mouse results are where the rubber meets the road. In diabetic burn models, wounds wrapped in the dAM-FP scaffold closed faster than with plain dAM or single-peptide versions. Histology confirmed it wasn’t just faster closure—it was better quality, with more microvessels and sensory nerves regenerating in sync.

Key takeaway: Combining neurogenic and angiogenic peptides on a natural ECM scaffold isn’t just additive, it’s synergistic. For anyone researching peptide-based biomaterials or regenerative medicine, this approach is a clear signal to look deeper into fusion peptide strategies.

Dig into more on fusion peptides and scaffold innovation in the peptide research index. If you’re sourcing peptides for bench work, check the vendor directory for your next project. Peptides are pushing the envelope—don’t sleep on this.

For Research Use Only

All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.